Follow the 네오이뮨텍 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 네오이뮨텍 has logged 52 reports. Market capitalisation: €8.7bn. The latest transaction was reported on 10 July 2026 (Purchase). Among the most active insiders: 양세환. Every trade is accessible without an account.
52
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
24 ops.
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
네오이뮨텍 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.
